Global Autism Spectrum Disorder Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Autism Spectrum Disorder market size was valued at US$ 9618 million in 2024 and is forecast to a readjusted size of USD 12060 million by 2031 with a CAGR of 3.3% during review period.

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child’s behavior and development to make a diagnosis. Our report studies the market from 2014-2025, examining programs and medications used to the patient with autism.

Symptoms and Signs

Autism spectrum disorders may manifest during the first year of life but, depending on severity of symptoms, diagnosis may not be clear until school age.

Two main features characterize autism spectrum disorders:

Persistent deficits in social communication and interaction

Restricted, repetitive patterns of behavior, interests, and/or activities

Both of these features must be present at a young age (although they may not be recognized at the time) and must be severe enough to significantly impair the child"s ability to function at home, school, or other situations. Manifestations must be more pronounced than expected for the child’s developmental level and adjusted for norms in different cultures.

Industry concentration is relatively low. The revenue market share of Otsuka is about 6%. The other competitors include AstraZeneca, Pfizer, Eli Lilly and Johnson & Johnson among others.

In terms of type, Autistic Disorder occupied a larger market share, Autistic Disorder occupied 35% market share in global Autism Spectrum Disorder Diagnosis and Therapeutics market.

This report is a detailed and comprehensive analysis for global Autism Spectrum Disorder market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Autism Spectrum Disorder market size and forecasts, in consumption value ($ Million), 2020-2031

Global Autism Spectrum Disorder market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Autism Spectrum Disorder market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Autism Spectrum Disorder market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Autism Spectrum Disorder

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Autism Spectrum Disorder market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Otsuka, AstraZeneca, Pfizer, Eli Lilly, Johnson & Johnson, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Autism Spectrum Disorder market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others

Market segment by Application
Children and Teenagers
Adults

Market segment by players, this report covers
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Autism Spectrum Disorder product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Autism Spectrum Disorder, with revenue, gross margin, and global market share of Autism Spectrum Disorder from 2020 to 2025.

Chapter 3, the Autism Spectrum Disorder competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Autism Spectrum Disorder market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Autism Spectrum Disorder.

Chapter 13, to describe Autism Spectrum Disorder research findings and conclusion.